Search
Use the filters to narrow by type of content
Looking for a Publication? Search the bibliography for: publications patient healthcare professional hcp general practitioner gp practice manager pm
… reimbursement is often of lower quality due to smaller patient populations available for clinical studies. Several … makes economic evaluations and subsequent application of general HTA rules challenging for orphan drug manufacturers. …
… II Time and Location: Sunday, December 11, 2022: 6:00 PM-8:00 PM Patients with hemophilia and their caregivers prefer … JC, DasMahapatra P, Bartelt-Hofer J. Poster Understanding patient preferences for chronic lymphocytic leukemia …
AMCP 2023 Share on: Tuesday, March 21 - Friday, March 24, 2023 Conference Website Research coauthored by RTI Health Solutions researchers will be presented at #AMCP2023. Does weight loss in addition to HbA1c reduction impact health care costs in patients …
Services You must make critical decisions in today’s complex, competitive, and highly regulated pharmaceutical, medical device, and diagnostics industry. However, often, the knowledge needed to make good clinical, market access, and safety decisions isn’t …
… the relative importance of benefits and risks and a patient’s maximum acceptable risk (MAR). If the actual risk …
… been among the leading voices in epidemiology training and practice for decades, having authored hundreds of manuscripts … for a generation of students and trainees. His list of professional awards and recognitions from professional societies, journals, and academic or research …
… New FDA Draft Guidance For Evaluating Patient-Reported Outcomes in Clinical Trials Share on: … for Selecting, Developing, Modifying, and Adapting Patient-Reported Outcome Instruments for Use in Medical … or health-monitoring devices) – this expands the usual practice of evidence derived from literature review, KOL …
… comments with the committee on 7 February 2024 at 12:00 pm. Public comments will provide the committee with … and supplementary data (e.g., natural history studies and patient registries) when evaluating the safety and efficacy …
… product’s treatment features, do you know how much your patient’s value it? Willingness-to-pay (WTP) can be estimated … benefit and can answer questions like what’s it worth to a patient if: The dosing regimen changes from 3 times a day to … for each study that are representative of the target patient population(s). Our experience includes numerous …
… to others, or integration of the payload gene into the patient's genome with possible formation of neoplasms. These novel concerns are raised in a setting of small patient populations and the need for decades-long follow up …